PharmaCyte Biotech, Inc. (PMCB) › Shareholders' EquityPharmaCyte Biotech, Inc. (PMCB) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: -$2.45M2011: -$2.73M2012: -$2.28M2013: -$1.50M2014: $8.94M2015: $7.78M2016: $6.52M2017: $8.09M2018: $5.77M2019: $5.04M2020: $5.09M2021: $6.68M2022: $89.92M2023: $72.69M2024: $27.65M2025: $51.89M$51.89M2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$51.89M+87.7%2024$27.65M-62.0%2023$72.69M-19.2%2022$89.92M+1246.2%2021$6.68M+31.3%2020$5.09M+1.0%2019$5.04M-12.6%2018$5.77M-28.7%2017$8.09M+24.0%2016$6.52M-16.1%2015$7.78M-13.0%2014$8.94M+695.6%2013-$1.50M+34.1%2012-$2.28M+16.5%2011-$2.73M-11.3%2010-$2.45M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share